Last reviewed · How we verify

Povidone (CROSPOVIDONE)

FDA-approved active Quality 16/100

Povidone (generic name: CROSPOVIDONE) is a Antiseptic [EPC] drug. It is currently FDA-approved for Red eye, Tear film insufficiency.

At a glance

Generic nameCROSPOVIDONE
Drug classAntiseptic [EPC]
Therapeutic areaOphthalmology
PhaseFDA-approved

Approved indications

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Povidone

What is Povidone?

Povidone (CROSPOVIDONE) is a Antiseptic [EPC] drug, indicated for Red eye, Tear film insufficiency.

What is Povidone used for?

Povidone is indicated for Red eye, Tear film insufficiency.

What is the generic name of Povidone?

CROSPOVIDONE is the generic (nonproprietary) name of Povidone.

What drug class is Povidone in?

Povidone belongs to the Antiseptic [EPC] class. See all Antiseptic [EPC] drugs at /class/antiseptic-epc.

What development phase is Povidone in?

Povidone is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing